BRPI0510946A - tratamento de asma em crianças - Google Patents

tratamento de asma em crianças

Info

Publication number
BRPI0510946A
BRPI0510946A BRPI0510946-9A BRPI0510946A BRPI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A
Authority
BR
Brazil
Prior art keywords
children
asthma treatment
asthma
treatment
glycopyrrolate
Prior art date
Application number
BRPI0510946-9A
Other languages
English (en)
Inventor
Susan Snape
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of BRPI0510946A publication Critical patent/BRPI0510946A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

TRATAMENTO DE ASMAS EM CRIANçAS O glicopirrolato ou um análogo dele é útil no tratamento da asma em crianças.
BRPI0510946-9A 2004-05-10 2005-05-10 tratamento de asma em crianças BRPI0510946A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410399.0A GB0410399D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001791 WO2005107873A2 (en) 2004-05-10 2005-05-10 Glycopyrrolate for treating childhood asthma

Publications (1)

Publication Number Publication Date
BRPI0510946A true BRPI0510946A (pt) 2007-11-20

Family

ID=32526760

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510946-9A BRPI0510946A (pt) 2004-05-10 2005-05-10 tratamento de asma em crianças

Country Status (15)

Country Link
US (1) US20070243260A1 (pt)
EP (1) EP1750807A2 (pt)
JP (1) JP2007536362A (pt)
KR (1) KR20070042917A (pt)
CN (1) CN1972730A (pt)
AU (1) AU2005240406A1 (pt)
BR (1) BRPI0510946A (pt)
CA (1) CA2565170A1 (pt)
GB (1) GB0410399D0 (pt)
IL (1) IL178816A0 (pt)
MX (1) MXPA06013040A (pt)
NO (1) NO20065536L (pt)
NZ (1) NZ550909A (pt)
WO (1) WO2005107873A2 (pt)
ZA (1) ZA200610264B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
CN102573912B (zh) * 2009-09-30 2014-01-01 三仪股份有限公司 难溶性物质的水溶性改善方法
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
SG181870A1 (en) 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
BR112012015334A2 (pt) 2009-12-23 2016-03-15 Chiesi Farma Spa terapia combinada para doença pulmonar obstrutiva crônica
KR20120106753A (ko) 2009-12-23 2012-09-26 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
EP2515855B3 (en) 2009-12-23 2023-05-03 Chiesi Farmaceutici S.p.A. Combination therapy for COPD
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
WO2013137009A1 (ja) * 2012-03-14 2013-09-19 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
RS57687B1 (sr) 2013-12-30 2018-11-30 Chiesi Farm Spa Pod pritiskom stabilan aerosolni rastvor kompozicije glikopironijum bromida i kombinacije formoterola
DK3689332T3 (da) 2014-09-09 2026-03-23 Vectura Ltd Formulering, som omfatter glycopyrrolat, fremgangsmåde og apparat
MY198321A (en) * 2015-11-16 2023-08-24 Chiesi Farm Spa A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
AU2019477296A1 (en) 2019-12-02 2022-04-14 Chiesi Farmaceutici S.P.A. Stainles steel can for pressurised metered dose inhalers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
WO2002043702A2 (en) * 2000-11-30 2002-06-06 Vectura Limited Pharmaceutical compositions for inhalation

Also Published As

Publication number Publication date
GB0410399D0 (en) 2004-06-16
IL178816A0 (en) 2007-05-15
NZ550909A (en) 2011-02-25
MXPA06013040A (es) 2007-02-12
EP1750807A2 (en) 2007-02-14
US20070243260A1 (en) 2007-10-18
AU2005240406A1 (en) 2005-11-17
CA2565170A1 (en) 2005-11-17
JP2007536362A (ja) 2007-12-13
NO20065536L (no) 2006-12-08
WO2005107873A3 (en) 2006-03-16
CN1972730A (zh) 2007-05-30
KR20070042917A (ko) 2007-04-24
WO2005107873A2 (en) 2005-11-17
ZA200610264B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
BRPI0510946A (pt) tratamento de asma em crianças
NL301145I2 (nl) Tirbanibulin
UA94221C2 (en) Lipocalin protein
MX2008006592A (es) Composiciones de edulcorante de alta potencia con calcio y composiciones edulcoradas con la misma
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
DE60213762D1 (de) Implementierung des SHA1 Algorithmusses
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
BRPI0510947A (pt) tratamento de doença respiratória
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
NO20071378L (no) Tiazolo-naftylsyrer.
JP2006502186A5 (ja) β-グルカンの使用
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200630367A (en) Substituted adenines and the uses thereof
EP1976548A4 (en) VIP FRAGMENTS AND APPLICATION PROCEDURES
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1625567A4 (en) SYSTEM FOR USING THE WHITE KEYS OF MUSIC INSTRUMENT KEYBOARDS FOR SELECTED RANGES
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE602005015297D1 (de) Verwendung von ozon zur verbesserung des knetvorgangs
GB2393571B (en) Improvements in and relating to the control of instruments
NO20053903D0 (no) Nukleotidlipidesterderivater.
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/00 (2006.01), A61P 11/06 (2006.01), A61K 3